Kairos Pharma Balance Sheet (2024-2025) | KAPA

Balance Sheet Sep2024 Dec2024 Mar2025 Jun2025
Assets
Current Assets
Cash & Equivalents 3.22M3.62M3.03M
Cash & Current Investments 3.22M3.62M3.03M
Prepaid Assets 0.01M0.04M0.06M0.09M
Current Assets 4.74M4.17M6.05M4.84M
Non-Current Assets
Intangibles 0.26M0.22M0.18M0.14M
Goodwill & Intangibles 0.26M0.22M0.18M0.14M
Other Non-Current Assets 1.38M1.71M1.69M
Non-Current Assets 0.26M1.60M1.89M1.83M
Assets 5.00M5.77M7.94M6.67M
Liabilities
Current Liabilities
Accounts Payables 1.53M0.99M0.81M0.68M
Notes Payables 0.79M
Payables 2.32M0.99M0.81M0.68M
Total Current Liabilities 1.67M0.99M0.81M0.68M
Non-Current Liabilities
Total Non-Current Liabilities 1.67M0.99M
Total Liabilities 1.67M0.99M0.81M0.68M
Shareholder's Equity
Common Equity 3.33M4.78M7.13M6.00M
Shareholder's Equity 3.33M4.78M7.13M6.00M
Liabilities and Shareholders Equity 5.00M5.77M7.94M6.67M
Retained Earnings -7.83M-8.81M-10.08M-11.50M
Treasury Shares 0.28M0.28M4.54M4.09M